Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 40 for your search:
Drug:  arsenic trioxide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: LAP-R2007, NCT00504764

2.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: Any age
Sponsor: Other
Protocol IDs: UHW-AML16, EU-20677, ISRCTN11036523, EUDRACT-2005-002846-14, MREC-CU106, NCT00454480

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Enrolling by invitation
Age: 18 to 75
Sponsor: Other
Protocol IDs: GDREC2013109H(R1), NCT01861912

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: APL0406, GIMEMA-SAL-APL0406, EUDRACT-2006-006188-22, GIMEMA-DSL-APL0406, EU-20725, NCT00482833

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000553210, S0521, U10CA032102, SWOG-S0521, NCT00492856

6.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 2 to 21
Sponsor: NCI
Protocol IDs: COG-AAML0631, COG-AAML0631, AAML0631, NCT00866918

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-03126, NCT00081133

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 0603-887, NCT00195104

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: Other
Protocol IDs: 2005-0893, NCT00469209

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 1888.00, FHCRC-1888.00, CDR0000380742, NCT00093366

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NU 04C1, CDR0000456504, STU00007792, NCT00275067

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000269319, OHSU-UCLA-0206062, OHSU-HEM-02001-L, OHSU-1096, NCT00053248

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: 11839A, UCCRC-11839A, NCI-5839, 5839, NCT00053222

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 02-402, CDR0000346366, UTMB-02402, NCT00075426

15.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MWCRG-CTI-T12017, MWCRG-03-82, MWCRG-WIRB-20040041

16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000433313, MUSC-MDS2773, MUSC-15348, NCT00118196

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: CDR0000438662, PCI-04-06060, CTI-PCI-04-06060, NCT00128596

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CCF6818, P30CA043703, CASE-CCF-6818, NCT00274781

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CASE4Y04, P30CA043703, CCF-7671, CASE-CCF-7671, NCT00274820

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 5 to 74
Sponsor: NCI, Other
Protocol IDs: J0442, CDR0000449985, P30CA006973, JHOC-J0442, WIRB-20041058, J0442, NCT00276601

21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-0354, NCT00201695

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: SCRI LYM 33, NCT00193518

23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 0604C, NCT00250042

24.

Phase: Phase II
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: 2006-0706, NCI-2012-01395, NCT00413166

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 07-108, P30CA008748, MSKCC-07108, CEPHALONO-MSKCC-07108, IRB 07-108, NCT00528450
1   
New Search